Merck settles Vioxx claims for $4.85bn
New York, November 9, 2007
Merck has agreed to pay $4.85 billion to settle US claims of heart attacks and strokes allegedly linked to its withdrawn painkiller Vioxx, the drugmaker said.
The agreement was reached with law firms on the steering committee for the federal Vioxx litigation as well as representatives of plaintiffs' counsel in state proceedings, Merck said.
It was signed after the parties met with three of the four judges overseeing the coordination of more than 95 per cent of the current claims in the Vioxx litigation, Merck said.
Merck said the deal is not a class action settlement and claims will be evaluated on an individual basis. Reuters
Tags: Merck |
More Health & Environment Stories
- Saudi confirms another death from new virus
- Men ‘at more risk from SARS-like virus’
- Wild poliovirus in the Horn of Africa
- Conference to be held at Burjeel hospital
- Tunisia confirms 2 cases of SARS-like virus
- Bahrain sets up team to combat new virus
- Bahrain sees 700pc rise in use of painkillers
- BCC joins global drive on heart disease
- NBK to fund hospital expansion
- Oman launches ME-first solar driven oil recovery